You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Disease, Hodgkin

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Classical Hodgkin Lymphoma, Non-Hodgkin Lymphoma Trial (GEN3017)

Not yet recruiting
  • Classical Hodgkin Lymphoma
  • Non-Hodgkin Lymphoma
  • GEN3017
  • (no location specified)
Aug 25, 2023

Hodgkin Lymphoma Trial in Cologne (Pembrolizumab)

Not yet recruiting
  • Hodgkin Lymphoma
  • Cologne, Germany
    1st Department of Medicine, Cologne University Hospital
Sep 19, 2023

Hodgkin Disease Trial in France (Morphological and functional magnetic resonance imaging (MRI), Neuropsychological assessment)

Not yet recruiting
  • Hodgkin Disease
  • Morphological and functional magnetic resonance imaging (MRI)
  • Neuropsychological assessment
  • Arras, France
  • +3 more
Oct 31, 2023

Classic Hodgkin Lymphoma Trial (Concurrent penpulimab and AVD, Sequential penpulimab and AVD)

Not yet recruiting
  • Classic Hodgkin Lymphoma
  • Concurrent penpulimab and AVD
  • Sequential penpulimab and AVD
  • (no location specified)
Jul 10, 2023

Cardiovascular Disease in Hodgkin Lymphoma Survivors

Not yet recruiting
  • Hodgkin Lymphoma
  • +3 more
  • Patient Self Reporting
  • +2 more
  • (no location specified)
Jan 20, 2023

Relapsed or Refractory Hodgkin Lymphoma Trial in Beijing (SHR2554+ SHR1701, SHR-1701)

Recruiting
  • Relapsed or Refractory Hodgkin Lymphoma
  • Beijing, Beijing, China
    Han wei dong
Jun 14, 2023

Quality of Life in Adult and Pediatric Nodular

Recruiting
  • Nodular Lymphocyte-Predominant Hodgkin Lymphoma
    • Aurora, Colorado
    • +1 more
    Oct 27, 2023

    Lymphoma, T-Cell, Cutaneous, Hodgkin Disease, Lymphoma, T-Cell, Peripheral Trial (SGN-35T)

    Not yet recruiting
    • Lymphoma, T-Cell, Cutaneous
    • +5 more
    • (no location specified)
    Nov 2, 2023

    Non-Hodgkin Lymphoma, Hodgkin Lymphoma Trial in Minneapolis (drug, procedure, biological, radiation)

    Recruiting
    • Non-Hodgkin Lymphoma
    • Hodgkin Lymphoma
    • Minneapolis, Minnesota
      Masonic Cancer Center, University of Minnesota
    Jan 25, 2023

    Hodgkin Lymphoma Trial in Houston (Brentuximab vedotin, Doxorubicin Hydrochloride, Pembrolizumab)

    Not yet recruiting
    • Hodgkin Lymphoma
    • Brentuximab vedotin
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jun 20, 2023

    Myocardial Injury in Hodgkin Lymphoma (HL) Survivors

    Active, not recruiting
    • Hodgkin Lymphoma Survivor
    • Clinical Assessment
    • +2 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Dec 22, 2022

    Hodgkin Lymphoma Trial in Valhalla (Brentuximab Vedotin, Doxorubicin, Vincristine)

    Active, not recruiting
    • Hodgkin Lymphoma
    • Brentuximab Vedotin
    • +3 more
    • Valhalla, New York
      New York Medical College
    Sep 27, 2022

    Hodgkin Lymphoma, Refractory Hodgkin Lymphoma, Relapsed Hodgkin's Disease, Adult Trial in Leon (Brentuximab Vedotin 50 MG

    Recruiting
    • Hodgkin Lymphoma
    • +2 more
    • Brentuximab Vedotin 50 MG [Adcetris]
    • Leon, Guanajuato, Mexico
      Hospital Regional Alta Especialidad Bajio
    Oct 24, 2022

    Resting Heart Rate and Heart Rate Variability in Survivors of

    Active, not recruiting
    • Hodgkin Disease
      • Memphis, Tennessee
        Kirsten Ness
      Jan 23, 2023

      Acute Lymphoblastic Leukemia, Hodgkin Disease, Allogeneic Stem Cell Transplantation Trial in Erlangen (Low-field magnetic

      Recruiting
      • Acute Lymphoblastic Leukemia
      • +2 more
      • Low-field magnetic resonance imaging
      • +3 more
      • Erlangen, Bavaria, Germany
        Department of Pediatrics and Adolescent Medicine
      Oct 23, 2023

      Hodgkin Lymphoma Trial in Salt Lake City (Axatilimab, Nivolumab)

      Not yet recruiting
      • Hodgkin Lymphoma
      • Salt Lake City, Utah
        Huntsman Cancer Institute at the University of Utah
      Feb 1, 2023

      Non-Hodgkin's Lymphoma and Hodgkin's Disease

      Recruiting
      • Lymphoma, Non-Hodgkin
      • Hodgkin's Disease
        • Stanford, California
          Stanford University School of Medicine
        Sep 9, 2022

        Hodgkin Lymphoma Trial (Tislelizumab, AVD, Radiotherapy)

        Not yet recruiting
        • Hodgkin Lymphoma
        • Tislelizumab, AVD, Radiotherapy
        • (no location specified)
        Nov 15, 2022

        Classical Hodgkin Lymphoma Trial in Philadelphia (Itacitinib, Everolimus)

        Active, not recruiting
        • Classical Hodgkin Lymphoma
        • Philadelphia, Pennsylvania
          Abramson Cancer Center of the University of Pennsylvania
        Nov 28, 2022

        Immunogenicity of COVID-19 Vaccinations in Autologous HSCT

        Not yet recruiting
        • COVID-19
        • +2 more
          • Cologne, NRW, Germany
            University Hospital of Cologne
          Oct 27, 2022

          Hodgkin Lymphoma Trial in Moscow (Nivolumab)

          Recruiting
          • Hodgkin Lymphoma
          • Moscow, Russian Federation
            National Research Center for Hematology
          Dec 13, 2022

          Hodgkin Lymphoma Trial in Saint Petersburg (Prolgolimab, Combination with prolgolimab and bendamustine)

          Recruiting
          • Hodgkin Lymphoma
          • Saint Petersburg, Russian Federation
          • +1 more
          Mar 3, 2023

          Hodgkin Lymphoma, Stage I Adult Hodgkin Lymphoma, Stage II Adult Hodgkin Lymphoma Trial in Rochester (drug, genetic, other)

          Withdrawn
          • Hodgkin Lymphoma
          • +4 more
          • Rochester, Minnesota
            Mayo Clinic
          Nov 28, 2022

          Brazilian Prospective Hodgkin Lymphoma Registry

          Recruiting
          • Hodgkin Lymphoma
          • Hodgkin Disease
            • Rio de Janeiro, Brazil
              Universidade Federal Do Rio de Janeiro
            May 16, 2022

            Classical Hodgkin Lymphoma Trial in Cologne (Nivolumab, Adriamycin, Vinblastine)

            Active, not recruiting
            • Classical Hodgkin Lymphoma
            • Cologne, Germany
              University Hospital of Cologne
            Aug 5, 2022